TTR and axial length measurement: In AL-CA median survival can be < 6 months from the time of diagnosis depending on the severity of cardiac involvement.6 ATTR amyloidosis has a longer disease course with a median survival of 3.6 years for the acquired, wild-type disease and varying prognosis for the hereditary type of disease, depending on the underlying transthyretin gene mutation.7